ED Summons Under PMLA - Indo Us Biotech

Enforcement RaidRegulatory & Legal View source PDF Explain this filing

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹121.00

prior close

₹121.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.4% vs market

Other Agricultural Products peers, median of 55sector+0.0%-0.4% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.4 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.0

15m

-0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.1-0.4+0.0-0.4

Next day

+0.7+1.3-0.6+0.5+0.2

+2.3+1.6+0.8+0.7+1.6

+0.5+2.5-2.0+0.9-0.5

-1.4+2.8-4.2+0.5-1.9

-2.7+2.1-4.8+0.2-2.9

-4.3+0.1-4.5-1.0-3.4

15d

-9.9-7.2-2.7-6.8-3.0

+2.9-4.4+7.3-6.0+8.9

+15.9-6.4+22.3-5.7+21.7

-19.5-15.1-4.4-17.0-2.5

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 55Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo Us Biotech received a summons from the Enforcement Directorate (ED), Raipur Zonal Office under the Prevention of Money Laundering Act (PMLA), 2002. Dated November 20, 2025 and received by mail on November 27, it requires the Principal Officer to appear and produce specific documents for investigation. No formal charges or orders have been passed yet. The company states there is no immediate material impact on its financial or operational activities. Disclosure was delayed due to internal review and legal assessment.

Likely market impact

ED probe creates uncertainty overhang; company says no immediate material impact, but outcome could affect sentiment and operations.